Updated:
Outram Bio
Outram Bio is an investment company based in Singapore. Founded in 2021, it focuses on investments in Asia. Outram Bio has made one investment, in Albatroz...
Outram Bio
Outram Bio is an investment company based in Singapore. Founded in 2021, it focuses on investments in Asia. Outram Bio has made one investment, in Albatroz Therapeutics, as part of a Seed VC round on April 25, 2023.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
Asia
Country
Singapore
City
Singapore
Corporate office
Singapore
Frequently asked questions
What is Outram Bio's core investment focus?
Outram Bio targets early-stage life sciences and biotechnology companies, primarily at the startup and Series A stages. The firm's mandate covers drug discovery, platform technologies, and therapeutic development. This singular focus on biotech distinguishes it from generalist technology and healthcare funds active in Asia.
Which sectors does Outram Bio explicitly avoid?
Outram Bio's mandate is narrowly focused on biotechnology and life sciences. Public information does not indicate the firm evaluates opportunities in consumer technology, fintech, enterprise software, real estate, or other non-healthcare verticals. Its exclusion profile is driven by sector concentration rather than an explicit avoidance list.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: